Search
Picodralazine
go.drugbank.com/drugs/DB21022ExperimentalPicodralazine is a small molecule drug. Picodralazine has a monoisotopic molecular weight of 251.12 Da.
Categories: picodralazine and diuretics, Hydrazinophthalazine Derivatives and DiureticsGuanosine-5'-Diphosphate
go.drugbank.com/drugs/DB04315ExperimentalA guanine nucleotide containing two phosphate groups esterified to the sugar moiety. [PubChem]
Pabinafusp alfa
go.drugbank.com/drugs/DB15633InvestigationalPabinafusp alfa is under investigation in clinical trial NCT03568175 (A Study of JR-141 in Patients With Mucopolysaccharidosis II).
Categories: Enzymes and Coenzymes, Alimentary Tract and MetabolismUpleganan
go.drugbank.com/drugs/DB21618InvestigationalUpleganan is under investigation in clinical trial NCT04865393 (Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function).
Pocenbrodib
go.drugbank.com/drugs/DB21616InvestigationalPocenbrodib is under investigation in clinical trial NCT06785636 (Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617).
Bucainide
go.drugbank.com/drugs/DB20650ExperimentalThe usage of the INN stem '-cain-' in the name indicates that Bucainide is a class I antiarrhythmic, procainamide and lidocaine derivative. Bucainide has a monoisotopic molecular weight of 329.28 Da.
Recainam
go.drugbank.com/drugs/DB20085ExperimentalThe usage of the INN stem '-cain-' in the name indicates that Recainam is a class I antiarrhythmic, procainamide and lidocaine derivative. Recainam has a monoisotopic molecular weight of 263.2 Da.
Milacainide
go.drugbank.com/drugs/DB20252ExperimentalThe usage of the INN stem '-cain-' in the name indicates that Milacainide is a class I antiarrhythmic, procainamide and lidocaine derivative.
Demoxytocin
go.drugbank.com/drugs/DB13798ExperimentalCategories: Pituitary and Hypothalamic Hormones and Analogues, Oxytocin and AnaloguesIsoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)-
go.drugbank.com/drugs/DB16204InvestigationalIsoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)- is under investigation in clinical trial NCT00545454 (Activity and Safety of Oral Administration of SSR150106XB for